Griswold Dp

1.1k total citations · 1 hit paper
19 papers, 885 citations indexed

About

Griswold Dp is a scholar working on Oncology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Griswold Dp has authored 19 papers receiving a total of 885 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 8 papers in Molecular Biology and 3 papers in Organic Chemistry. Recurrent topics in Griswold Dp's work include Cancer therapeutics and mechanisms (6 papers), Cancer Treatment and Pharmacology (4 papers) and Synthesis and biological activity (2 papers). Griswold Dp is often cited by papers focused on Cancer therapeutics and mechanisms (6 papers), Cancer Treatment and Pharmacology (4 papers) and Synthesis and biological activity (2 papers). Griswold Dp collaborates with scholars based in United States. Griswold Dp's co-authors include Schabel Fm, Laster Wr, Corbett Th, Trader Mw, Skipper He, Linda Simpson‐Herren, Wilcox Ws, WP Peters and Emil Frei and has published in prestigious journals such as Cancer Research, PubMed and Munich Personal RePEc Archive (Ludwig Maximilian University of Munich).

In The Last Decade

Griswold Dp

19 papers receiving 763 citations

Hit Papers

cis-Dichlorodiammineplatinum(II): combination chemotherap... 1980 2026 1995 2010 1980 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. cis-Dichlorodiammineplatinum(II): combination chemotherapy and cross-resistance studies with tumors of mice.
    1980 357 citations Schabel Fm, Trader Mw et al. PubMed profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Griswold Dp United States 14 496 338 187 118 102 19 885
Laster Wr United States 18 574 1.2× 433 1.3× 242 1.3× 126 1.1× 116 1.1× 28 1.2k
Trader Mw United States 12 402 0.8× 290 0.9× 152 0.8× 103 0.9× 95 0.9× 16 718
Corbett Th 8 377 0.8× 267 0.8× 143 0.8× 112 0.9× 90 0.9× 8 652
B D Evans New Zealand 11 362 0.7× 217 0.6× 115 0.6× 77 0.7× 99 1.0× 24 728
Von Hoff United States 16 540 1.1× 295 0.9× 171 0.9× 113 1.0× 34 0.3× 39 1.1k
NH Mulder Netherlands 18 644 1.3× 510 1.5× 130 0.7× 107 0.9× 103 1.0× 58 1.1k
D. J. Th. Wagener Netherlands 18 506 1.0× 311 0.9× 401 2.1× 236 2.0× 109 1.1× 57 1.1k
P. J. Burke United States 14 549 1.1× 343 1.0× 160 0.9× 88 0.7× 65 0.6× 27 1.0k
M. Lehnert Switzerland 19 702 1.4× 361 1.1× 154 0.8× 87 0.7× 88 0.9× 40 1.1k
M. Satya Murthy United States 16 267 0.5× 273 0.8× 104 0.6× 78 0.7× 47 0.5× 36 726

Countries citing papers authored by Griswold Dp

Since Specialization
Citations

This map shows the geographic impact of Griswold Dp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Griswold Dp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Griswold Dp more than expected).

Fields of papers citing papers by Griswold Dp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Griswold Dp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Griswold Dp. The network helps show where Griswold Dp may publish in the future.

Co-authorship network of co-authors of Griswold Dp

This figure shows the co-authorship network connecting the top 25 collaborators of Griswold Dp. A scholar is included among the top collaborators of Griswold Dp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Griswold Dp. Griswold Dp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Dp, Griswold, et al.. (1990). Evaluation of combinations of interferons and cytotoxic drugs in murine tumor models in vivo.. PubMed. 9(4). 395–400. 3 indexed citations
2.
Wr, Laster, et al.. (1990). Antitumor activity of ethyl 5-amino-1,2-dihydro-2-methyl-3-phenyl-pyrido [3,4-b]pyrazin-7-ylcarbamate, 2-hydroxyethanesulfonate, hydrate (NSC 370147) against selected tumor systems in culture and in mice.. Cancer Research. 50(11). 3239–44. 20 indexed citations
3.
Dp, Griswold, et al.. (1987). Response of drug-sensitive and -resistant L1210 leukemias to high-dose chemotherapy.. PubMed. 47(9). 2323–7. 25 indexed citations
4.
Dp, Griswold, et al.. (1987). Therapeutic synergy of trimetrexate (CI-898) in combination with doxorubicin, vincristine, cytoxan, 6-thioguanine, cisplatin, or 5-fluorouracil against intraperitoneally implanted P388 leukemia.. PubMed. 99–104. 11 indexed citations
5.
Dp, Griswold. (1986). Body burden of cancer in relationship to therapeutic outcome: consideration of preclinical evidence.. PubMed. 70(1). 81–6. 12 indexed citations
6.
Fm, Schabel, Skipper He, Trader Mw, et al.. (1983). Establishment of cross-resistance profiles for new agents.. PubMed. 67(10). 905–22. 92 indexed citations
7.
Th, Corbett, et al.. (1982). Response of transplantable tumors of mice to anthracenedione derivatives alone and in combination with clinically useful agents.. PubMed. 66(5). 1187–200. 37 indexed citations
8.
Dp, Griswold, Corbett Th, & Schabel Fm. (1981). Clonogenicity and growth of experimental tumors in relation to developing resistance and therapeutic failure.. PubMed. 65 Suppl 2. 51–4. 8 indexed citations
9.
Fm, Schabel, Trader Mw, Laster Wr, Corbett Th, & Griswold Dp. (1980). cis-Dichlorodiammineplatinum(II): combination chemotherapy and cross-resistance studies with tumors of mice.. PubMed. 63(9-10). 1459–73. 357 indexed citations breakdown →
10.
Fm, Schabel, Skipper He, Trader Mw, et al.. (1980). Concepts for controlling drug-resistant tumor cells.. PubMed. Suppl 1. 199–211. 43 indexed citations
11.
Th, Corbett, et al.. (1979). Design and evaluation of combination chemotherapy trials in experimental animal tumor systems.. PubMed. 63(5). 799–801. 21 indexed citations
12.
Th, Corbett, et al.. (1978). Biology and therapeutic response of a mouse mammary adenocarcinoma (16/C) and its potential as a model for surgical adjuvant chemotherapy.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 62(10). 1471–88. 82 indexed citations
13.
Dp, Griswold, et al.. (1974). Approaches to combination chemotherapy in rat, mouse, and hamster tumors.. PubMed. 4(1). 99–108. 2 indexed citations
14.
Dp, Griswold. (1972). Consideration of the subcutaneously implanted B16 melanoma as a screening model for potential anticancer agents.. PubMed. 3(1). 315–24. 24 indexed citations
15.
Dp, Griswold, Linda Simpson‐Herren, & Schabel Fm. (1970). Altered sensitivity of a hamster plasmacytoma to cytosine arabinoside (NSC-63878).. PubMed. 54(5). 337–46. 14 indexed citations
16.
Wr, Laster, et al.. (1969). Success and failure in the treatment of solid tumors. II. Kinetic parameters and "cell cure" of moderately advanced carcinoma 755.. PubMed. 53(3). 169–88. 41 indexed citations
17.
Wr, Laster, et al.. (1969). Toxicity studies in mice treated with 1-beta-D-arabinofuranosylcytosine (ara-C).. PubMed. 29(3). 529–35. 31 indexed citations
18.
Dp, Griswold, Schabel Fm, Wilcox Ws, Linda Simpson‐Herren, & Skipper He. (1968). Success and failure in the treatment of solid tumors. I. Effects of cyclophosphamide (NSC-26271) on primary and metastatic plasmacytoma in the hamster.. PubMed. 52(3). 345–87. 27 indexed citations
19.
Ws, Wilcox, Griswold Dp, Laster Wr, Schabel Fm, & Skipper He. (1965). Experimental evaluation of potenital anticancer agents. XVII. Kinetics of growth and regression after treatment of certain solid tumors.. PubMed. 47. 27–39. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laster Wr Breakdown of academic impact, for papers by Trader Mw Breakdown of academic impact, for papers by Corbett Th Breakdown of academic impact, for papers by B D Evans Breakdown of academic impact, for papers by Von Hoff Breakdown of academic impact, for papers by NH Mulder Breakdown of academic impact, for papers by D. J. Th. Wagener Breakdown of academic impact, for papers by P. J. Burke Breakdown of academic impact, for papers by M. Lehnert Breakdown of academic impact, for papers by M. Satya Murthy
Rankless by CCL
2026